Skip to main content

Market Overview

5 Value Stocks In The Healthcare Sector

Share:

Understanding Value Stocks

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

The following stocks are considered to be notable value stocks in the healthcare sector:

  1. Amneal Pharmaceuticals (NYSE:AMRX) - P/E: 9.31
  2. Coherus BioSciences (NASDAQ:CHRS) - P/E: 9.19
  3. SunLink Health Systems (AMEX:SSY) - P/E: 6.41
  4. Cooper Companies (NYSE:COO) - P/E: 9.08
  5. Global Cord Blood (NYSE:CO) - P/E: 7.81

Amneal Pharmaceuticals's earnings per share for Q4 sits at 0.14, whereas in Q3, they were at 0.16. Amneal Pharmaceuticals does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

This quarter, Coherus BioSciences experienced a decrease in earnings per share, which was 0.47 in Q3 and is now 0.23. Coherus BioSciences does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

SunLink Health Systems has reported Q2 earnings per share at 0.46, which has increased by 1250.0% compared to Q1, which was -0.04. SunLink Health Systems does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Most recently, Cooper Companies reported earnings per share at 3.17, whereas in Q4 earnings per share sat at 3.16. Its most recent dividend yield is at 0.02%, which has ('', 'not changed') by 0.0% from 0.02% in the previous quarter.

See also: Best Healthcare Penny Stocks

Global Cord Blood has reported Q3 earnings per share at 0.15, which has decreased by 6.25% compared to Q2, which was 0.16. Global Cord Blood does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

 

Related Articles (AMRX + CHRS)

View Comments and Join the Discussion!

Posted-In: BZI-VSEarnings News Dividends

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com